Immune Booster

Immune Booster

This study is currently active

Purpose:

The purpose of this study is to determine if the new medication can prevent symptomatic respiratory illness in patients 65 and over.

Study Length:

20 weeks with 8 office visits; compensation of $450.

Study Procedure: 

Physical Exam, heart & respiratory rate, ECG, blood work, labs, urinalysis.

Qualifications: 

  • Male or females 65
  • Patients who require no or minimal assistance with self-care and daily activities
  • Patient who are non-smokers -or- quit smoking 1 year prior to screening
  • No presence of any other clinically significant lung disease
  • Special focus on patients with asthma, heart failure, 85 and older

Participate in a Study

Submit the form and a clinical study expert will get in touch with you.

Want to know more about our clinical trials?

Leave a Reply